Dr. Mohammad Ali Ansari, MD

Dr. Ansari practices at Elite Surgery Center of Beverly Hills in Los Angeles, California.

Dr. Ansari's NPI, 1164520581, was assigned on September 20, 2006. Dr. Ansari graduated from UC Irvine School of Medicine in 1991. Dr. Ansari holds California license G75046.

Dr. Ansari's primary practice is Elite Surgery Center of Beverly Hills, at 6310 W San Vicente Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 589-4001.

Dr. Ansari's primary practice is Elite Surgery Center of Beverly Hills in Los Angeles, California. Dr. Ansari is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Ansari to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ansari practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Ansari's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Ansari is board certified in pulmonary disease by the American Board of Internal Medicine. Dr. Ansari is licensed in California.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia and pulmonary fibrosis among the conditions Dr. Ansari treats.

CMS data shows 3,768 Medicare services from Dr. Ansari across 22 procedure codes in 2024, for 753 Medicare patients. Medicare paid $345,291 for them.

CMS counts 753 Medicare patients who saw Dr. Ansari in 2024. The largest group is 65 to 74, with 275 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ansari's median patient age at 73, with 42% women.

In 2024, Dr. Ansari wrote 2,685 Medicare Part D claims for 322 patients. 61% of them were for generic drugs. CMS names the drug for 2,267 of them, across 64 drugs with 11 or more claims each, at $563,322 in total drug cost. In 2023, CMS named 2,305 claims across 61 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ansari for performance year 2024, reported as part of a group. Dr. Ansari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ansari as offering telehealth.

Dmand AI links 27 papers to Dr. Ansari, published from 2011 to 2024. 2018 was the busiest year, with 5. The most frequent topics are Phantoms, Imaging, beta Carotene and Image Interpretation, Computer-Assisted. Dr. Ansari has published most often in Biomed Opt Express. Dr. Ansari's most frequent co-author is Eishi Asano, MD, PhD.

CMS Open Payments shows 244 general payments to Dr. Ansari from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. GlaxoSmithKline, LLC. paid the most, $1,660.

Dmand AI lists 1 award for Dr. Ansari, most recently Cedars-Sinai Medical Center in 1994.

Dr. Ansari graduated from UC Irvine School of Medicine in 1991. Dr. Ansari is a member of AASM and ACCP.

Dr. Ansari is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.